Phathom PharmaceuticalsPHAT

那斯達克 · USD
9.74
+0.34
(+3.62%)
收盤 08/09 03:59 (UTC+8)
盤後 
9.47 
9.47 
(-2.77%)
08/09 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • 0.01
  • 0.02
  • 0.07
  • 0.16
  • 0.30
  • 0.29
  • 0.40
icon
  • -
  • -
  • -
  • -
  • 180.35
  • 283.05
  • 123.27
  • 81.41
  • -3.86
  • 38.51
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
營業收入淨額
39,503
28,519
29,664
16,352
7,324
1,912
682
-
-
-
營業成本
5,0383,7243,8152,3561,376426167---
營業毛利
34,465
24,795
25,849
13,996
5,948
1,486
515
-
-
-
營業費用
94,389103,658---71,44070,39035,65931,70130,077
研發費用
9,0769,1848,5838,6937,3769,43013,39412,26312,76311,479
推銷及管理費用
85,31394,47476,68376,09975,87262,01056,99623,39618,93818,598
非經常性項目費用
----------
其他營業費用
----------
營業利益
-59,924
-78,863
-59,417
-70,796
-77,300
-69,954
-69,875
-35,659
-31,701
-30,077
其他收入及費用
-2,6183,5593,7033,6184,2703,3342,5233511,480
利息費用
17,51818,07118,59318,48417,76417,16813,02910,1079,6159,217
稅前純益
-75,810
-94,316
-74,451
-85,577
-91,446
-82,852
-79,570
-43,243
-40,965
-37,814
所得稅
----------
稅後純益
-75,810
-94,316
-74,451
-85,577
-91,446
-82,852
-79,570
-43,243
-40,965
-37,814
基本每股稅後盈餘(元)
-1.05-1.31-1.05-1.32-1.56-1.42--0.76-0.84-0.89
稀釋每股稅後盈餘(元)
-1.05-1.31-1.00-1.31-1.56-1.42-1.45-0.75-0.84-0.89
基本平均股數(千股)
72466.0071969.0071044.0064627.0058558.0058371.00-56782.0048500.0042354.00
稀釋平均股數(千股)
72466.0071969.0071044.0064627.0058558.0058371.00-56782.0048500.0042354.00
還原基本每股稅後盈餘(元)
-1.05-1.31-1.05-1.32-1.56-1.42--0.76-0.84-0.89
還原稀釋每股稅後盈餘(元)
-1.05-1.31-1.00-1.31-1.56-1.42-1.45-0.75-0.84-0.89
還原基本平均股數(千股)
72,46671,96971,04464,62758,55858,371-56,78248,50042,354
還原稀釋平均股數(千股)
72,46671,96971,04464,62758,55858,371-56,78248,50042,354
EBITDA(千元)
-58,120-75,372-55,036-66,313-72,985-64,996-65,790-32,473-30,954-27,955

大家都在看

HOT